Zhonghong Pulin Medical Products Co (300981) Fair Value & Analysis
Healthcare · CN · Market cap 4.6B CNY
Fair value as of: Jul 9, 2026
From 2 valuation models · updated today
Fair value updated Jul 9, 2026 — revised from ¥55.20 to ¥5.24 (−90.5%) since Jun 24, 2026. Share price −13.7% over the past month.
Price vs Fair Value (12 months)
12‑month range ¥9.50 – ¥17.32 · fair‑value band ¥3.85 – ¥6.62 · the ¥10.04 price screens above the ¥5.24 fair value. As of Jul 9, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Zhonghong Pulin Medical Products Co (300981) currently trades at ¥10.04, while our model-based Fair Value estimate is ¥5.24 — implying the stock looks roughly 47.8% overvalued today. We read business quality at 41/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, Zhonghong Pulin Medical Products Co generated revenue of 2.3B CNY at a net margin of -5.4%. Revenue declined 4.3% year over year. It earns a return on equity of -2.4%. Net debt stands at 133M CNY. Fundamentals as of Jul 9, 2026
Our scenario range runs from ¥3.85 (bear case) to ¥6.62 (bull case); at ¥10.04, the current price sits above that range. The share trades about 45% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -44% fair-value upside — at -48%, 300981 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 9, 2026. TTM = trailing twelve months.
About the company
Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health products for medical and industrial use in China and internationally. It operates in three segments: Health Protection Division; Safety Infusion Division; and Innovation Incubation Division. The Health Protection Division offers nitrile gloves, PVC gloves, natural latex gloves, radiation-proof gloves, polyisoprene gloves, examination findom, and condoms, as well as various other disposable exam, surgical, and protective gloves. Its Safety Infusion Division provides infusion equipment-related products, such as precision infusion sets, indwelling needles, common infusion sets, common syringes, and blood collection tubes, etc. The Innovation Incubation Division offers infusion and syringe pumps, infusion information collection systems, disposable non-invasive EEG electrodes, disposable medical temperature sensors, non-invasive …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Zhonghong Pulin Medical Products Co reported revenue of ¥2.4B in FY2025 versus ¥4.9B in FY2021, a compound −16.6%/yr. Reported net income was −¥112M in FY2025.
Is 300981 fairly valued? → Check now
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.95 | $182.39 | -55% |
| EssilorLuxottica Société anonyme ESLOF | $205.86 | $114.90 | -44% |
| HOYA Corporation HOCPY | $162.33 | $101.00 | -38% |
| Medline Inc MDLN | $33.61 | $31.78 | -5% |
| Becton, Dickinson and Company BDX | $143.92 | $104.17 | -28% |
| Alcon Inc ALC | $66.11 | $36.99 | -44% |
| ResMed Inc R1MD34 | R$253.26 | R$41.40 | -84% |
| West Pharmaceutical Services, Inc WST | $329.71 | $137.28 | -58% |
| Terumo Corporation TRUMF | $14.62 | $12.65 | -13% |
| Straumann Holding SAUHY | $12.68 | $5.49 | -57% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Zhonghong Pulin Medical Products Co (300981) undervalued?
What is the fair value of 300981?
What is the quality score of 300981?
What is the revenue of Zhonghong Pulin Medical Products Co (300981)?
What is the net profit margin of 300981?
Does Zhonghong Pulin Medical Products Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.